<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15631">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02903394</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00070555</org_study_id>
    <secondary_id>R01CA167421</secondary_id>
    <nct_id>NCT02903394</nct_id>
  </id_info>
  <brief_title>Coherence Imaging of the Cervical Epithelium</brief_title>
  <official_title>Coherence Imaging of the Cervical Epithelium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jacobi Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a multiplexed low coherence interferometry (mLCI)
      endoscopic probe for mapping the epithelial types of the cervix. This vaginal mLCI probe
      will obtain optical measurements from the cervix. These measurements can be used to create a
      map of the surface cells that distinguishes ectocervical epithelia, endocervical epithelia,
      and the squamocolumnar junction (t-zone), which is the region where cervical dysplasia is
      most likely to occur.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>distinguish types of cervical epithelium</measure>
    <time_frame>day 1</time_frame>
    <description>measured by: ability to differentiate between endocervical epithelia, ectocervical epithelia, and squamocolumnar junction (t-zone) between them</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>margins of t-zone</measure>
    <time_frame>day 1</time_frame>
    <description>measured as the area between the endocervical (columnar) epithelia and the ectocervical (squamous) epithelia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number and frequency of adverse events</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cervical Epithelia</condition>
  <arm_group>
    <arm_group_label>mLCI imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mLCI device images cervical epithelium</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>mLCI Device</intervention_name>
    <description>imaging of cervical epithelium using mLCI device</description>
    <arm_group_label>mLCI imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  able to provide informed consent

          -  willing to abstain from sexual intercourse for at least 24 hours before study visit

        Exclusion Criteria:

          -  pregnant

          -  using an intrauterine device (IUD)

          -  have a current gynecological infection or discharge

          -  have had any cervical surgery

          -  had medical or cosmetic surgery involving the reproductive organs or genitals within
             the past 6 months

          -  currently enrolled in any research studies involving the application of vaginal
             formulations

          -  employed or supervised by the study investigators

          -  have any other condition, that, in the opinion of the study clinician, would
             contraindicate participation in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Wax, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adam Wax, Ph.D.</last_name>
    <phone>919-660-5143</phone>
    <email>a.wax@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Peters, B.S.</last_name>
    <phone>919-660-5226</phone>
    <email>jennifer.peters@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jacobi Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael J Zinaman, M.D.</last_name>
      <phone>718-918-6300</phone>
      <email>michael.zinaman@nbhn.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>September 12, 2016</lastchanged_date>
  <firstreceived_date>September 1, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
